NBC News reports that the U.S. Food and Drug Administration expects to issue an emergency permit next week, possibly even earlier, for the Pfizer COVID-19 vaccine for children between 12 and 15 years old.
According to Josh Geballe, Connecticut’s Chief Operating Officer, there are approximately 177,000 children in this age group in Connecticut.
While this group of 12 to 15 year olds are not at high risk for serious coronavirus infections, they can still contract COVID-19, have symptoms and spread it to other more vulnerable populations, said Dr. Juan Salazar, Connecticut Pediatrician-in-chief .
NBC News reports that the U.S. Food and Drug Administration expects to approve the Pfizer vaccine for ages 12 to 15 next week, possibly even earlier.
Newington’s mother, Grisel Contreres, has a 15-year-old son. He is aware of all of his other vaccines, and Contreres said she is not completely opposed to the COVID shot, but she doesn’t think now is the best time.
“As a parent, I just wouldn’t feel comfortable vaccinating them from the age of 12 and 15. I think a little bit older I would probably feel a bit more comfortable. It’s just real, there are too many unknowns, ”said Contreres.
The biggest unknown to her is how the vaccine might affect her son in the long term.
Doctor Salazar said he would recommend that parents weigh the risks of their children getting the vaccine versus getting COVID-19.
“We’re starting a study here in Connecticut, looking at long-haul vehicles and possibly how the infection affects the learning environments, heart, muscles, joints, growth and development and overall behavior of young children, and we remember that. not. So with all this unknown information about the actual disease, I would like to prevent it, ”said Salazar. “The vaccine is one that uses only a small component that mimics the virus protein, the spike protein. It generates immunity. It doesn’t affect every organ the way COVID does, so it’s a much more limited potential risk. “
If the FDA grants emergency authorization for the Pfizer vaccine in people between 12 and 15 years old, the federal vaccine advisory committee would meet and decide whether the vaccine is recommended. When the CDC then takes over the accompaniment, recording can begin.